Prime Medicine (PRME) Change in Account Payables (2021 - 2026)

Prime Medicine (PRME) has 6 years of Change in Account Payables data on file, last reported at $3.6 million in Q1 2026.

• Quarterly Change in Account Payables rose 88.54% year-over-year to $3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.7 million (up 6.26% YoY) and the FY2025 annual result came in at $996000.0, up 118.95% from the prior year.
• Change in Account Payables advanced to $3.6 million in Q1 2026, from -$581000.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $5.8 million in Q3 2023 to a low of -$5.9 million in Q1 2024.
• A 5-year average of $640529.4 and a median of $1.4 million in 2022 frame the typical range for Change in Account Payables.
• Annual changes were most pronounced in 2023 — Change in Account Payables jumped 1535.66% — and 2024, when it slumped 1066.67%.
• Tracing PRME's Change in Account Payables over 5 years: stood at $431000.0 in 2022, then soared by 428.77% to $2.3 million in 2023, then advanced by 7.94% to $2.5 million in 2024, then sank by 123.62% to -$581000.0 in 2025, then soared by 711.36% to $3.6 million in 2026.
• The last three Change in Account Payables figures came in at $3.6 million (Q1 2026), -$581000.0 (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.